Improving Response Inhibition in Parkinson’s Disease with Atomoxetine-Reference-Cited by-同舟云学术

Improving Response Inhibition in Parkinson’s Disease with Atomoxetine

Published:2015-04 Issue:8 Volume:77 Page:740-748
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Ye Zheng,Altena Ellemarije,Nombela Cristina,Housden Charlotte R.,Maxwell Helen,Rittman Timothy,Huddleston Chelan,Rae Charlotte L.,Regenthal Ralf,Sahakian Barbara J.,Barker Roger A.,Robbins Trevor W.,Rowe James B.

Funder

Wellcome Trust

Medical Research Council

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference62 articles.

1. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease;Cools;Neuropsychologia,2003

2. Prospective prevalence pathologic gambling and medication association in Parkinson disease;Voon;Neurology,2006

3. Association of dopamine agonist use with impulse control disorders in Parkinson disease;Weintraub;Arch Neurol,2006

4. Serotonin neuron loss and nonmotor symptoms continue in Parkinson’s patients treated with dopamine grafts;Politis;Sci Transl Med,2012

5. Catechols in post-mortem brain of patients with Parkinson disease;Goldstein;Eur J Neurol,2011

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microstructural properties of attention-related white matter tracts are associated with the renewal effect of extinction;Behavioural Brain Research;2024-08

2. Neural alterations underlying executive dysfunction in Parkinson’s disease: A systematic review and coordinate-based meta-analysis of functional neuroimaging studies.;Ageing Research Reviews;2024-03

3. Noradrenergic modulation of saccades in Parkinson’s disease;2024-01-05

4. Trajectories and contributing factors of neural compensation in healthy and pathological aging;Neuroscience & Biobehavioral Reviews;2024-01

5. Identification, Synthesis, and Characterization of Potential Dichloro Impurity: N,N-Dimethyl-3-Phenyl-2, 3-Dichloropropylamine in the Synthesis of Atomoxetine;Pharmaceutical Chemistry Journal;2023-11